Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Monocyte abundance and glycolytic reprogramming associate with motivational impairment in depression.
Journal: Brain, behavior, and immunity
Published: March 30, 2026
Effects of Dopaminergic Therapy with Levodopa (L-DOPA) on Fear and Anxiety-Related Circuits and Symptoms in Patients with Depression and Higher Inflammation.
Journal: Brain, behavior, and immunity
Published: September 09, 2025
Polygenic score for C-reactive protein is associated with accelerated cortical thinning and increased psychopathology in adolescents: a population-based longitudinal cohort study.
Journal: Research square
Published: July 09, 2025
The new normal: neural network adaptations in late-life depression.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: May 25, 2025
Designing Clinical Trials for an Inflammatory Subtype of Major Depressive Disorder.
Journal: Biological psychiatry
Published: February 17, 2025
Not All Neuroinflammation Is Created Equal: The Dual Nature of Astrogliosis.
Journal: Biological psychiatry
Published: January 28, 2025
Inflammation is associated with avolition and reduced resting state functional connectivity in corticostriatal reward circuitry in patients with schizophrenia.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: December 12, 2024
Lipids and C-reactive protein predict anhedonia and reward circuit functional connectivity responses to anti-cytokine and dopaminergic therapies in patients with depression.
Journal: Comprehensive psychoneuroendocrinology
Published: October 08, 2024
Sustained effects of repeated levodopa (L-DOPA) administration on reward circuitry, effort-based motivation, and anhedonia in depressed patients with higher inflammation.
Journal: Brain, behavior, and immunity
Published: September 02, 2024
Rewiring the brain: Inflammation's impact on glutamate and neural networks in depression.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: July 17, 2024
A randomized proof-of-mechanism trial of TNF antagonism for motivational anhedonia and related corticostriatal circuitry in depressed patients with high inflammation.
Journal: Research square
Published: March 18, 2024
Last Updated: 09/26/2026